SCHEMBL10632003

SCHEMBL10632003

CC(=O)Oc1ccc(C(=O)O)c(C2=CCC(C)(C)[C@@H]3CC[C@@H]4[C@]5(CC[C@]6(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@]46C)C[C@]235)c1

nearest known ligand 0.36

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ EBP Q15125 6/20 0.36
▸ ACLY P53396 2/20 0.36
▸ ACACA Q13085 2/20 0.36
▸ CDC25B P30305 8/20 0.35
▸ HMGCR P04035 1/20 0.34
▸ HSD11B1 P28845 2/20 0.33
▸ PTPN11 Q06124 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10635664 0.94 EBP (0.37) EBPACLYACACACDC25BHMGCR
SCHEMBL10638467 0.90 EBP (0.38) EBPACLYACACACDC25BHMGCR
SCHEMBL10638347 0.89 EBP (0.40) EBPACLYACACACDC25BHMGCR
SCHEMBL10349522 0.88 ACLY (0.35) EBPACLYACACACDC25BHMGCR
SCHEMBL10634881 0.88 EBP (0.38) EBPACLYACACACDC25BHMGCR
SCHEMBL10635634 0.87 PRKAG1 (0.37) EBPACLYACACACDC25BHMGCR
SCHEMBL10632132 0.86 EBP (0.36) EBPACLYACACACDC25BHMGCR
SCHEMBL10635522 0.85 EBP (0.38) EBPACLYACACACDC25BHMGCR
SCHEMBL10635500 0.85 EBP (0.38) EBPACLYACACACDC25BHMGCR
SCHEMBL10634936 0.82 EBP (0.38) EBPACLYACACACDC25BHMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4748161-A Triterpenyl esters of organic acids and hypolipidemic agents composed of them AMANO PHARMACEUTICAL CO., LTD. (JP) 1988-05-31 — — US disclosed
EP-0166542-A2 Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them AMANO PHARMACEUTICAL CO., LTD. (JP) 1986-01-02 — — EP disclosed
Send feedback